Jacobs Engineering Group Inc. (NYSE:JEC) announced today that it was awarded a contract from Bayer CropScience Australia to perform early stage engineering for an expansion project at their formulation plant in Kwinana, Western Australia.
Officials did not disclose the contract value.
Jacobs is generating and updating as-built site documentation to develop a design and cost estimate for a new bulk unloading and mixing system. After early stage engineering, subject to required approvals, Bayer intends to proceed the project into engineering procurement and construction management phases.
The project is expected to significantly increase Bayer’s production capability at Kwinana and improve its ability to service the Western Australian agricultural sector.Jacobs Group Vice President Tom Quinn stated, “We are delighted to be working with Bayer on this important capacity expansion project. We look forward to supporting the project objectives by integrating our strong local capability in the region, along with our global sector experience.” The Kwinana operation is responsible for formulation and distribution of broadacre products for Western Australia, and supporting South Australia and Victoria. Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, responsible for the agricultural business, is one of the world’s leading crop science companies in the areas of seeds, crop protection and non-agricultural pest control. Jacobs is one of the world's largest and most diverse providers of technical, professional, and construction services. Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management’s current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2012 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts